Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Elenza Inc.
Start-Up Quarterly Statistics, Q1 2011
Biopharma and medical device start-ups brought in a total of $216 million in Q1 2011. Absent were any financings involving in vitro diagnostics companies. Only four acquisitions involving start-ups were completed - one in biopharma and three in the device industry. Cancer was the most popular therapeutic category among biopharma start-up alliance this quarter.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Recent Financings of Private Companies (04/11)
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.